# 



## 




## 

## 

|||`Unrestricted Funds`|`Unrestricted Funds`|`Unrestricted Funds`|||
|---|---|---|---|---|---|---|
|||`Capital`|||`2021`|`2020`|
|||`Fund`||`General Fund`|`Total`|`Total`|
||`Note`|`£`||`£`|`£`|`£`|
|`Income and endowments`|||||||
|`Investment income`|||||||
|`Investment income`|`3`||`-`|`98,324.74`|`98,324.74`|`208,132`|
|`Book sales`|||<br>`-`|<br>`351,96`|<br>`351.96`|<br>`542`|
|`Total income and endowments`||<br>|<br> <br>`-`|<br> <br>`98,676.70`|<br> <br>`98,676.70`|<br> <br>`208,674`|
|`Expenditure on:`|||||||
|`Costs ofraising funds`|||||||
|`Investment managementcosts`|`4`||`-`|`27,115.68`|`27,115.68`|`50,301`|
|`Charitable activities`|||||||
|`Grants and donations`<br>`Accountancy`<br>`Independent examination`<br>`Bank charges`<br>`Administration`|`aaaan`||`-`<br>`-`<br>`-`<br>`-`<br>`-`|`141,701.96`<br>`6,900.00`<br>`1,200.00`<br>`69.45`<br>`6,000.00`|`141,701.96`<br>`6,900.00`<br>`1,200.00`<br>`69.45`<br>`6,000.00`|`349,792`<br>`4,800`<br>`1,200`<br>`37`<br>`6,000`|
|`Total expenditure`||<br>|<br> <br>`:`|<br> <br>`182,987.09`|<br> <br>`182,987.09`|<br> <br>`412,130`|
|`Net gain/(loss) on listed investments`<br>`Net gain/(loss) on unlisted investments`|`oo`||<br>`-`<br>`z`|<br>`1,580,211.61`<br>`o`|<br>`1,580,211.61`<br>`=`|<br>`( 1,109,659)`<br>`(99,589)`|
|`Net (expenditure)/incomeand net`|||||||
|`movementin funds`|||`-`|`1,495,901.22`|`1,495,901.22`|`(1,412,704)`|
|`Reconciliation of funds`|||||||
|`Total funds brought forward`||<br>`7,000.00`||<br>`5,100,249.72`|<br>`5,107,249.72`|<br>`6,519,954`|
|`Total funds carried forward`||`7,000.00`<br>||`6,596,150.94`<br>|`6,603,150.94`<br>|`5,107,250`<br>|





















##